Zecuity

Active Ingredient(s): Sumatriptan
FDA Approved: * January 17, 2013
Pharm Company: * NUPATHE INC
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zecuity Overview

Sumatriptan is a medication used for the treatment of migraine headaches.[1] It is a synthetic drug belonging to the triptan class. Structurally, it is an analog of psilocybin, and features an N-methyl sulfonamidomethyl group at position C-5 on the indole ring.[2] Sumatriptan is produced and marketed by various drug manufacturers with many different trade names such as Imitrex, Imigran, Sumatran, Sumatriptanum, and Sumax, also as Treximet as an oral combinatio...

Read more Zecuity Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sumatriptan

Recent Zecuity Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sumatriptan
  • Injection: 3mg/0.5ml, 4mg/0.5ml (8mg/ml), 6mg, 6mg/0.5ml, 6mg/0.5ml (12mg/ml), 6mg/0.5ml (6mg/0.5ml)
  • Powder: 11mg, 22mg
  • Solution: 3mg/0.5ml (3mg/0.5ml)
  • Spray: 10mg/spray, 20mg/spray, 5mg/spray
  • Spray, Metered: 20mg/actuation, 5mg/actuation
  • System: 6.5mg, 6.5mg/4hr
  • Tablet: 100mg, 25mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zecuity: (1 result)

Sorted by National Drug Code
  • 51759-101 Zecuity 6.5 mg/4h Transdermal Patch, Extended Release, Electrically Controlled by Nupathe Inc.

Other drugs which contain Sumatriptan or a similar ingredient: (8 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA